Bank of Stockton’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $715K | Sell |
2,842
-1,015
| -26% | -$218K | 0.2% | 79 |
|
|
2026
Q1 | $839K | Buy |
3,857
+69
| +2% | +$15.3K | 0.26% | 67 |
|
|
2025
Q4 | $866K | Sell |
3,788
-375
| -9% | -$85.4K | 0.25% | 65 |
|
|
2025
Q3 | $964K | Sell |
4,163
-126
| -3% | -$25.7K | 0.27% | 58 |
|
|
2025
Q2 | $796K | Sell |
4,289
-15
| -0.3% | -$2.79K | 0.24% | 59 |
|
|
2025
Q1 | $902K | Sell |
4,304
-523
| -11% | -$102K | 0.29% | 54 |
|
|
2024
Q4 | $858K | Sell |
4,827
-987
| -17% | -$181K | 0.26% | 55 |
|
|
2024
Q3 | $1.15M | Sell |
5,814
-796
| -12% | -$149K | 0.35% | 47 |
|
|
2024
Q2 | $1.13M | Sell |
6,610
-1,745
| -21% | -$289K | 0.36% | 47 |
|
|
2024
Q1 | $1.52M | Sell |
8,355
-156
| -2% | -$26.9K | 0.47% | 41 |
|
|
2023
Q4 | $1.4M | Sell |
8,511
-224
| -3% | -$32.7K | 0.46% | 41 |
|
|
2023
Q3 | $1.27M | Sell |
8,735
-219
| -2% | -$32.1K | 0.47% | 40 |
|
|
2023
Q2 | $1.21M | Sell |
8,954
-75
| -0.8% | -$11K | 0.41% | 42 |
|
|
2023
Q1 | $1.44M | Buy |
9,029
+759
| +9% | +$116K | 0.5% | 34 |
|
|
2022
Q4 | $1.34M | Sell |
8,270
-680
| -8% | -$104K | 0.47% | 41 |
|
|
2022
Q3 | $1.2M | Sell |
8,950
-794
| -8% | -$114K | 0.46% | 45 |
|
|
2022
Q2 | $1.49M | Buy |
9,744
+746
| +8% | +$114K | 0.56% | 35 |
|
|
2022
Q1 | $1.46M | Buy |
8,998
+1,717
| +24% | +$249K | 0.46% | 46 |
|
|
2021
Q4 | $986K | Sell |
7,281
-925
| -11% | -$109K | 0.29% | 56 |
|
|
2021
Q3 | $885K | Sell |
8,206
-170
| -2% | -$19.4K | 0.27% | 61 |
|
|
2021
Q2 | $943K | Buy |
8,376
+214
| +3% | +$24.1K | 0.28% | 59 |
|
|
2021
Q1 | $883K | Buy |
8,162
+3,459
| +74% | +$370K | 0.29% | 58 |
|
|
2020
Q4 | $503K | Hold |
4,703
| – | – | 0.19% | 74 |
|
|
2020
Q3 | $411K | Sell |
4,703
-290
| -6% | -$27.3K | 0.17% | 81 |
|
|
2020
Q2 | $490K | Buy |
4,993
+257
| +5% | +$22.6K | 0.21% | 77 |
|
|
2020
Q1 | $360K | Sell |
4,736
-196
| -4% | -$16.7K | 0.2% | 76 |
|
|
2019
Q4 | $436K | Sell |
4,932
-475
| -9% | -$39.4K | 0.18% | 80 |
|
|
2019
Q3 | $409K | Sell |
5,407
-5,536
| -51% | -$380K | 0.18% | 83 |
|
|
2019
Q2 | $795K | Sell |
10,943
-1,999
| -15% | -$157K | 0.4% | 54 |
|
|
2019
Q1 | $1.04M | Sell |
12,942
-225
| -2% | -$18.4K | 0.54% | 45 |
|
|
2018
Q4 | $1.21M | Sell |
13,167
-1,805
| -12% | -$159K | 0.74% | 36 |
|
|
2018
Q3 | $1.42M | Sell |
14,972
-1,286
| -8% | -$122K | 0.72% | 36 |
|
|
2018
Q2 | $1.51M | Sell |
16,258
-25
| -0.2% | -$2.44K | 0.82% | 30 |
|
|
2018
Q1 | $1.54M | Buy |
16,283
+2,725
| +20% | +$299K | 0.64% | 38 |
|
|
2017
Q4 | $1.31M | Buy |
13,558
+2,972
| +28% | +$280K | 0.54% | 43 |
|
|
2017
Q3 | $940K | Buy |
10,586
+3,304
| +45% | +$252K | 0.43% | 48 |
|
|
2017
Q2 | $528K | Sell |
7,282
-480
| -6% | -$32.3K | 0.24% | 68 |
|
|
2017
Q1 | $505K | Buy |
7,762
+500
| +7% | +$31.4K | 0.23% | 68 |
|
|
2016
Q4 | $455K | Sell |
7,262
-267
| -4% | -$16.3K | 0.22% | 68 |
|
|
2016
Q3 | $475K | Hold |
7,529
| – | – | 0.24% | 67 |
|
|
2016
Q2 | $466K | Sell |
7,529
-2
| -0% | -$122 | 0.25% | 65 |
|
|
2016
Q1 | $430K | Buy |
7,531
+811
| +12% | +$45.2K | 0.23% | 72 |
|
|
2015
Q4 | $398K | Buy |
6,720
+125
| +2% | +$7.2K | 0.23% | 69 |
|
|
2015
Q3 | $359K | Sell |
6,595
-100
| -1% | -$6.51K | 0.22% | 72 |
|
|
2015
Q2 | $450K | Hold |
6,695
| – | – | 0.25% | 66 |
|
|
2015
Q1 | $392K | Sell |
6,695
-300
| -4% | -$18.1K | 0.21% | 72 |
|
|
2014
Q4 | $458K | Sell |
6,995
-125
| -2% | -$7.88K | 0.26% | 66 |
|
|
2014
Q3 | $411K | Sell |
7,120
-323
| -4% | -$17.9K | 0.24% | 69 |
|
|
2014
Q2 | $420K | Sell |
7,443
-70
| -0.9% | -$3.67K | 0.24% | 70 |
|
|
2014
Q1 | $386K | Sell |
7,513
-695
| -8% | -$35.1K | 0.24% | 74 |
|
|
2013
Q4 | $433K | Sell |
8,208
-20
| -0.2% | -$983 | 0.27% | 66 |
|
|
2013
Q3 | $368K | Sell |
8,228
-245
| -3% | -$10.9K | 0.26% | 72 |
|
|
2013
Q2 | $350K | Buy |
+8,473
| New | +$371K | 0.27% | 80 |
|
Other funds holding ABBV
Bank of Stockton's ABBV Position: Q2 2026 in Review
Bank of Stockton reduced its AbbVie (ABBV) stake by 26% in Q2 2026, selling an estimated $218K and leaving 2,842 shares worth $715K. The position accounts for 0.2% of the portfolio, ranked #79.
Bank of Stockton first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.54M in Q1 2018. 2,661 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Bank of Stockton held 2,842 shares of AbbVie worth $715K as of Q2 2026.
- Bank of Stockton sold 1,015 AbbVie shares in Q2 2026, an estimated $218K.
- AbbVie made up 0.2% of Bank of Stockton's portfolio in Q2 2026, its #79 holding.
- Bank of Stockton first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Bank of Stockton's AbbVie position peaked at $1.54M in Q1 2018.
- 2,661 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Bank of Stockton's 13F filing for Q2 2026, filed 29 Jul 2026.